Tenon Medical, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Tenon Medical, Inc. (TNON) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 4.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-27
- Tenon Medical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 4.00%, a 33.33% increase from fiscal 2023.
- Tenon Medical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 3.00%, a 200.00% increase from fiscal 2022.
- Tenon Medical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 1.00%, a 50.00% decline from fiscal 2021.
- Tenon Medical, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 2.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-31 | 4.00% 10-K · filed 2026-03-27 |
| 2023-12-31 | 3.00% 10-K · filed 2025-03-26 |
| 2022-12-31 | 1.00% 10-K · filed 2024-03-29 |
| 2021-12-31 | 2.00% 10-K · filed 2023-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |